Integer Holdings Corporation

Integer Holdings trades at a P/E of 27.8, commanding a notable premium despite RSI of 45.1 suggesting neither momentum nor oversold conditions—just neutral positioning. At $2.9B market cap, the company sits meaningfully below its 52-week high, yet the valuation multiple remains elevated for a medical device manufacturer in a cyclical sector. This disconnect hints at either unpriced growth expectations or overvaluation relative to current fundamentals. The absence of short interest data limits conviction on squeeze potential, but the premium P/E paired with moderate technicals leaves limited margin for disappointment on near-term earnings.